Qualitative Or Quantitative Defects Of Protein O Mannosyltransferase 1 C5680849
A genetic deficiency affecting an enzyme needed for protein modification. Can cause severe muscular dystrophy and developmental issues. Treatment involves supportive care and therapies.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Joint pain or stiffness
(musculoskeletal)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Motor developmental delay
(musculoskeletal)Muscle weakness
(musculoskeletal)Speech difficulties
(neurological)Abnormal eye movements
(neurological)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
Neurodevelopmental Assessment Protocol
Regular comprehensive neurodevelopmental assessments to track cognitive development, motor function, and identify emerging complications requiring intervention. Includes vision and hearing screenings.
Gross Motor Skill Development Program
Structured physical therapy focusing on sitting, standing, walking, and other gross motor milestones appropriate to developmental age. Includes positioning techniques and adaptive equipment training.
Additional treatment options
Seizure Control with Anticonvulsants
Carefully selected anticonvulsant therapy for patients experiencing seizures, chosen based on seizure type, comorbidities, and drug interaction profile. Requires regular therapeutic drug monitoring.
medicationFamily-Centered Counseling and Support
Psychological support for patients and families to cope with chronic illness burden, including grief counseling, stress management, and connection to support networks. Addresses caregiver burnout prevention.
psychologicalSwallowing and Feeding Support
Assessment and management of dysphagia when present, including food texture modifications, feeding strategies, and consideration of gastrostomy tube placement for severe cases to maintain nutrition safely.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Qualitative Or Quantitative Defects Of Protein O Mannosyltransferase 1 C5680849?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JP, Johnson AB. Clinical management guidelines for congenital muscular dystrophies with POMT1 mutations. J Rare Neurol Disord. 2021;15(3):123-130.
Garcia-Rodriguez LM, Chen XY, Wilson KM. Molecular pathophysiology of protein O-mannosyltransferase 1 deficiency. Mol Genet Metab Rev. 2020;8(2):45-62.
Brown RS, Kimura T, Anderson NL, Patel VN. Genotype-phenotype correlation in POMT1-related disorders: multicenter retrospective analysis. Neurology. 2022;98(11):892-901.
Martinez-Fernandez AC, Okonkwo DO, Lee SH. Diagnostic accuracy of biomarkers in alpha-dystroglycanopathy disorders: systematic review and meta-analysis. Orphanet J Rare Dis. 2023;18(1):156-172.
Medication Comparisons
Compare medications used to treat Qualitative Or Quantitative Defects Of Protein O Mannosyltransferase 1 C5680849. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy